Inovio Pharmaceuticals(DE:GBM)
€1.26-0.02 (-1.80%)
DE:GBM
Inovio Pharmaceuticals earnings date
€1.26
At close:-0.02 (-1.80%)
Inovio Pharmaceuticals (GBM) Q2 2022 Earnings Report
6 Followers
DE:GBM Q2 2022 EPS Results
- Actual EPS
- -EUR 5.02
- Consensus EPS
- -EUR 3.38
- Beat/Miss
- Missed by -EUR 1.64
- One Year Ago EPS
- -EUR 4.26
DE:GBM Q2 2022 Revenue Results
- Actual Revenue
- EUR 713.59K
- Expected Revenue
- EUR 481.25K
- Beat/Miss
- Beat by +EUR 232.34K
- YoY Revenue Growth
- +187.51%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/09/2022
- Time
- After Close
- Conference Call
- Tuesday, August 9, 2022
DE:GBM Upcoming Earnings
Inovio Pharmaceuticals's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:GBM Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -0.12- | 0.05 | ― | ― |
| Nov 10, 2026 | 2026 (Q3) | -0.19-0.45 | -0.79 | 42.53% (+0.34) | |
| Aug 12, 2026 | 2026 (Q2) | -0.20-0.06 | -0.55 | 88.52% (+0.49) | |
| May 13, 2026 | 2026 (Q1) | -0.32-0.25 | -0.46 | 45.10% (+0.21) | |
| Mar 12, 2026 | 2025 (Q4) | -0.330.05 | -0.59 | 109.23% (+0.65) | |
| Nov 10, 2025 | 2025 (Q3) | -0.38-0.79 | -0.81 | 2.25% (+0.02) | |
| Aug 12, 2025 | 2025 (Q2) | -0.55-0.55 | -1.08 | 48.74% (+0.53) | |
| May 13, 2025 | 2025 (Q1) | -0.63-0.46 | -1.19 | 61.07% (+0.73) | |
| Mar 18, 2025 | 2024 (Q4) | -0.76-0.59 | -1 | 40.91% (+0.41) | |
| Nov 14, 2024 | 2024 (Q3) | -1.05-0.81 | -1.42 | 42.95% (+0.61) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

